Aloha is asking “how is that a price sensitive announcement?”. I am not replying to him/her/they, however anyone who is thinking the same and is not familiar with investing in medical development companies, every trial announcement is always price sensitive by default. And Aloha also learned something today from FLIESH
Ann: First Patient enrolled - SynPath Diabetic Foot Ulcer Trial, page-20
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.21 |
Change
0.040(1.84%) |
Mkt cap ! $1.525B | |||
| Open | High | Low | Value | Volume |
| $2.20 | $2.24 | $2.18 | $2.216M | 1.003M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 21397 | $2.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.22 | 6000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.22 |
Change
0.040 ( 1.94 %) |
||||
| Open | High | Low | Volume | ||
| $2.18 | $2.24 | $2.18 | 232838 | ||
| Last updated 15.59pm 05/06/2024 ? | |||||
| PNV (ASX) Chart |